Výsledky vyhledávání - "Carlotta, Santelmo"

Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: A meta-analysis of randomized clinical trials

Autor: Emiliano Tamburini, Davide Tassinari, Lorenzo Gianni, Britt Rudnas, Claudio Ridolfi, Stefania Nicoletti, Fabrizio Drudi, Carlotta Santelmo

Publikováno v: Critical Reviews in Oncology/Hematology. 104:115-123

In stage IV colorectal cancer, bevacizumab-based maintenance therapy, complete stop therapy and continuous therapy are considered all possible approaches after first line induction chemotherapy. However, there are no clear data about which approach i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137ec44a83e6c5f270955d8ac42953ca
https://doi.org/10.1016/j.critrevonc.2016.05.016

Zobrazit plný text záznamu

Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer

Autor: Francesco Montanari, Manuela Fantini, Emiliano Tamburini, Carlotta Santelmo, Fabrizio Drudi, Sergio Sartori, L. Stocchi, Lorenzo Gianni, Davide Tassinari

Publikováno v: Reviews on recent clinical trials. 11(4)

Background: To assess the role of docetaxel plus androgen deprivation in metastatic, hormone- sensitive prostate cancer. Methods: A qualitative systematic review of literature was performed. All the randomized phase III trials comparing docetaxel plu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0d84bd9344856590d6570ee3e39631
https://pubmed.ncbi.nlm.nih.gov/27448518

Zobrazit plný text záznamu

Triple Negative Breast Cancer Treatment: Use of Platinum and Platinum Analogs

Autor: Lorenzo Gianni, Claudio Ridolfi, Alessandra Affatato, Eleonora Barzotti, Fabrizio Drudi, Carlotta Santelmo, Alberto Ravaioli, Valentina Arcangeli, Manuela Fantini

Publikováno v: Journal of Cancer Therapy. :777-781

Triple negative breast cancer (TNBC) is characterized by a high sensitivity to antiblastic drugs and a high pathological complete remission rate after neoadjuvant therapy. In patients showing complete remission, the probability of developing metastat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c218dfd357b657592229c90ea0ee435c
https://doi.org/10.4236/jct.2012.325097

Zobrazit plný text záznamu

Second-Line Treatments in Non-small Cell Lung Cancer

Autor: Paola Tombesi, Carlotta Santelmo, Emiliano Tamburini, Luigi Lazzari-Agli, Sergio Sartori, Emanuela Scarpi, Davide Tassinari

Publikováno v: Chest. 135:1596-1609

Background To assess the efficacy of second-line treatments in non-small cell lung cancer. Methods A systematic review of literature with metaanalysis of randomized clinical trials was independently performed by three authors. A primary analysis incl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ab8b708d94edc059fc68d70e0e83868
https://doi.org/10.1378/chest.08-1503

Zobrazit plný text záznamu

Second Line Treatments in Advanced Platinum-Resistant Non Small Cell Lung Cancer. A Critical Review of Literature

Autor: Federica Carloni, Sergio Sartori, Emiliano Tamburini, Paola Tombesi, Luigi Lazzari Agli, Carlotta Santelmo, Davide Tassinari

Publikováno v: Reviews on Recent Clinical Trials. 4:27-33

In the last 10 years the medical approach to platinum-resistant Non Small Cell Lung Cancer (NSCLC) has radically changed, passing from a lack of evidence of any primary treatment against the tumor, to the identification of chemotherapy or EGFR inhibi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e431bff0912c279b244e49cb31ba09
https://doi.org/10.2174/157488709787047549

Zobrazit plný text záznamu

Coexistence of EGFR mutation and ALK translocation in NSCLC: Literature review and case report of response to gefitinib

Autor: Maximilian Papi, Fabrizio Drudi, Alberto Ravaioli, M. Salvi, Barbara Poggi, Carlotta Santelmo, L. Crinò, M. Mangianti, E. Barzotti

Publikováno v: Lung Cancer. 81:294-296

The coexistence of EGFR and ALK-EML4 gene mutations represents a rare event (about 1%) in patients with non small cell lung cancer (NSCLC) and the few cases described in the literature have all been treated by different methods. We present the case o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d843ddda40e55fdf475eedc8ffdc2bd7
https://doi.org/10.1016/j.lungcan.2013.04.009

Zobrazit plný text záznamu

Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report

Autor: A. Polselli, Carlotta Santelmo, Giuseppe Pasini, Eleonora Barzotti, Claudio Ridolfi, Fabrizio Drudi, Alberto Ravaioli

Publikováno v: Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 7, Iss 1, p 29 (2013)

Introduction Uterine leiomyosarcoma is one of the most frequent uterine sarcomas. In the metastatic setting it is sensitive to doxorubicin, ifosfamide, gemcitabine, docetaxel and a few other drugs, but time to progression is generally short. For this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0244b907799eb3c1c282d8ae42a989b8
https://doi.org/10.1186/1752-1947-7-29

Zobrazit plný text záznamu

Radically resected pancreatic cancer and adjuvant treatment. A review of the literature

Autor: Fabrizio, Drudi, Davide, Tassinari, Jacopo, Giuliani, Claudio, Ridolfi, Lorenzo, Gianni, Emiliano, Tamburini, Manuela, Fantini, Carlotta, Santelmo, Eleonora, Barzotti, Nadia, Lotti, Alberto, Ravaioli

Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Results from randomized clinical trials confirmed the efficacy of adjuvant therapy for pancreatic cancer but did not define what is the "right choice" i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a6286c9d34fa094dde6343f24b3af7dc
http://hdl.handle.net/11585/191733

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání